NO975567D0 - Preparat med kontrollert frigivelse av aktiv substans - Google Patents

Preparat med kontrollert frigivelse av aktiv substans

Info

Publication number
NO975567D0
NO975567D0 NO975567A NO975567A NO975567D0 NO 975567 D0 NO975567 D0 NO 975567D0 NO 975567 A NO975567 A NO 975567A NO 975567 A NO975567 A NO 975567A NO 975567 D0 NO975567 D0 NO 975567D0
Authority
NO
Norway
Prior art keywords
controlled
active substance
release active
substance preparation
preparation
Prior art date
Application number
NO975567A
Other languages
English (en)
Other versions
NO975567L (no
NO312815B1 (no
Inventor
Herman Marder
Lawrence Kirschner
John J Steinke
Andrew D Kurtz
Poul Bertelsen
Nils Gjerlov Hansen
Thyge Borup Hjorth
Original Assignee
Church & Dwight Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Church & Dwight Co Inc filed Critical Church & Dwight Co Inc
Publication of NO975567D0 publication Critical patent/NO975567D0/no
Publication of NO975567L publication Critical patent/NO975567L/no
Publication of NO312815B1 publication Critical patent/NO312815B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19975567A 1995-06-06 1997-12-03 Preparat med kontrollert frigivelse av aktiv substans NO312815B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/472,693 US5674529A (en) 1995-06-06 1995-06-06 Alkalinizing potassium salt controlled release preparations
PCT/US1996/009016 WO1996039127A1 (en) 1995-06-06 1996-06-06 Alkalinizing potassium salt controlled release preparations

Publications (3)

Publication Number Publication Date
NO975567D0 true NO975567D0 (no) 1997-12-03
NO975567L NO975567L (no) 1998-02-05
NO312815B1 NO312815B1 (no) 2002-07-08

Family

ID=23876566

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975567A NO312815B1 (no) 1995-06-06 1997-12-03 Preparat med kontrollert frigivelse av aktiv substans

Country Status (18)

Country Link
US (1) US5674529A (no)
EP (1) EP0840598A4 (no)
JP (1) JPH11506778A (no)
KR (1) KR19990022537A (no)
CN (1) CN1106837C (no)
AR (1) AR003131A1 (no)
AU (1) AU698784B2 (no)
BR (1) BR9608392A (no)
CA (1) CA2223281A1 (no)
CO (1) CO4700033A1 (no)
CZ (1) CZ288129B6 (no)
HU (1) HUP9900856A2 (no)
NO (1) NO312815B1 (no)
NZ (1) NZ310138A (no)
PL (1) PL323939A1 (no)
SK (1) SK167797A3 (no)
WO (1) WO1996039127A1 (no)
ZA (1) ZA964427B (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4759099A (en) * 1998-09-21 2000-03-23 Mcneil-Ppc, Inc. Heat stable antacid and antigas suspensions
JP5014554B2 (ja) * 2000-06-14 2012-08-29 ジェイカムアグリ株式会社 被覆生物活性粒状物の製造方法
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
FR2837100B1 (fr) * 2002-03-18 2004-07-23 Flamel Tech Sa Comprimes a bases de microcapsules a liberation modifiee
CA2480824A1 (fr) 2002-04-09 2003-10-16 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee d'amoxicilline
DE60325709D1 (de) 2002-04-09 2009-02-26 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
US20040109889A1 (en) * 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
CA2559670A1 (en) * 2003-04-14 2004-10-28 Gabor Pragai Stable amlodipine maleate formulations
PL2207526T3 (pl) 2007-10-12 2018-06-29 Ferring International Center S.A. Sposób wytwarzania produktu farmaceutycznego zawierającego kwas cytrynowy, tlenek magnezu, wodorowęglan potasu i pikosiarczan sodu, kompozycja farmaceutyczna zawierająca granulki otrzymane takim sposobem i jego produkty pośrednie
FR2967578B1 (fr) * 2010-11-18 2012-12-28 Advicenne Pharma Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3538214A (en) * 1969-04-22 1970-11-03 Merck & Co Inc Controlled release medicinal tablets
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet
US4259315A (en) * 1980-06-13 1981-03-31 A. H. Robins Company, Inc. Controlled release potassium dosage form
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
DK152744C (da) * 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
DE3586600T2 (de) * 1984-02-10 1993-02-18 Benzon Pharma As Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend.
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
CH658188A5 (de) * 1984-03-23 1986-10-31 Ciba Geigy Ag Lagerstabile schnellzerfallende pharmazeutische presslinge.
CA1270765A (en) * 1985-02-19 1990-06-26 Charles Hsiao Controlled release potassium chloride
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
US4822619A (en) * 1987-02-18 1989-04-18 Ionor, Inc. Controlled release pharmaceutical preparation containing a gastrointestinal irritant drug
US5035898A (en) * 1987-11-27 1991-07-30 Schering Corporation Potassium/magnesium supplement
ATE145825T1 (de) * 1988-10-21 1996-12-15 Univ California Behandlung von erhöhtem blutdruck
US5171583A (en) * 1988-10-21 1992-12-15 The Regents Of The University Of California Treatment of osteoporosis using potassium bicarbonate
US5498428A (en) * 1988-10-21 1996-03-12 The Regents Of The University Of California Treatment of hypertension by oral administration of potassium bicarbonate
DE3838094A1 (de) * 1988-11-10 1990-05-17 Nordmark Arzneimittel Gmbh Feste pharmazeutische retardform
US5077051A (en) * 1990-04-10 1991-12-31 Warner-Lambert Company Sustained release of active agents from bioadhesive microcapsules
US5445805A (en) * 1993-05-06 1995-08-29 Church & Dwight Co., Inc. Large potassium bicarbonate crystals and process for the preparation thereof

Also Published As

Publication number Publication date
AR003131A1 (es) 1998-07-08
JPH11506778A (ja) 1999-06-15
EP0840598A1 (en) 1998-05-13
PL323939A1 (en) 1998-04-27
CZ288129B6 (cs) 2001-04-11
KR19990022537A (ko) 1999-03-25
NO975567L (no) 1998-02-05
HUP9900856A2 (hu) 1999-08-30
NO312815B1 (no) 2002-07-08
EP0840598A4 (en) 2001-08-29
CN1187121A (zh) 1998-07-08
US5674529A (en) 1997-10-07
AU698784B2 (en) 1998-11-05
AU6047396A (en) 1996-12-24
NZ310138A (en) 1999-04-29
SK167797A3 (en) 1998-06-03
CA2223281A1 (en) 1996-12-12
WO1996039127A1 (en) 1996-12-12
ZA964427B (en) 1997-02-24
BR9608392A (pt) 1999-11-30
CN1106837C (zh) 2003-04-30
CZ389297A3 (cs) 1998-06-17
CO4700033A1 (es) 1998-12-29

Similar Documents

Publication Publication Date Title
NO973938D0 (no) Farmasöytisk preparat av piperdinoalkanolforbindelser
NO973612D0 (no) Nytt farmasöytisk preparat
EE9800116A (et) Farmatseutiliselt aktiivsed kinasoliini ühendid
DK0839039T4 (da) Paroxetinpræparater med styret frigivelse
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
NO995533D0 (no) Ny fremgangsmåte for fremstilling av en farmakologisk aktiv substans
DK1093815T3 (da) Oral 2-methyl-thieno-benzodiazepinformulering
PT869126E (pt) Derivados de ditiolano, sua preparacao e seus efeitos terapeuticos
BR9610153A (pt) Formulações farmacêuticas
BR9611626A (pt) Formulações farmacéuticas
EE04293B1 (et) Stabiilsed lüofiliseeritud ravimvormid
BR9610396A (pt) Formulação farmacêutica
NO982324L (no) Preparat med regulert avgivelse av biologisk aktiv forbindelse
DK0805625T3 (da) Insekticidt aktiv sammensætning
BR9610214A (pt) Compostos farmacéuticos
NO975567D0 (no) Preparat med kontrollert frigivelse av aktiv substans
NO973471D0 (no) Transdermal formulering
BR9607722A (pt) Formulação transdérmica
NO973610D0 (no) Nytt farmasöytisk preparat
NO975680D0 (no) Oralt, farmasöytisk preparat av piperidinoalkanol-forbindelser i opplösningsform
NO973611D0 (no) Nytt farmasöytisk preparat
NO950950D0 (no) Farmasöytisk preparat
NO980384L (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
NO971879D0 (no) Preparat for transdermal administrasjon
NO965448D0 (no) Farmasöytiske forbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees